Preliminary Programme

  • 9.00 - 11.35: Neurosurgery Arnold-Chiari

    Chairpersons: Peter Spazzapan, Tita Butenko

    Time Authors Title
    9.00 - 9.20 Peter Spazzapan,
    Pediatric neurosurgery, UMCL    		 Pathogenesis and natural history of Chiari malformation
    9.20 - 9:40 Tita Butenko
    Pediatric neurology, UMCL    		 Neurological examination in Chiari malformation
    9.40 - 10:00 Francesco Tuniz
    Neurosurgery, Udine, Italy    		 Syringomyelia and Chiari malformation
    10.00 - 10.20 Miha Vodičar
    Orthopedic clinic, UMCL    		 Scoliosis and Chiari malformation
    10.20 - 10.40 Karin Pristacher
    Neurosurgery, Graz, Austria    		 Associated malformations: craniosynostosis, hydrocephalus, tethered cord
    10.40 - 11.00 Valentina Baro, Luca Denaro
    Pediatric neurosurgery, Padova, Italy    		 Neurosurgical indications - Are we operating too many children?
    11.00 - 11.20 Giorgio Giuffre, Marina Mazzucco
    Neurosurgery, Treviso, Italy    		 Neurosurgical techniques and complications
    11.20 - 11.35 Discussion  

    11.35 - 11.55: Coffee break
    11.55 - 13.40: Neuromuscular / Rare 1

    Chairpersons: Tanja Loboda, Ivan Lehman
    Time Authors Title
    11.55 - 12.40 Guillaume Canaudndres
    Hôpital Necker-Enfants Malades, France    		 PIK3CA PROS
    13.00 - 13.20 Eva Vrščaj, Tanja Loboda, Damjan Osredkar
    UMCL, Slovenia    		 SMA patients switchig from nusinersen to risdiplam
    13.20 - 13.40 Eva Vrščaj, Damjan Osredkar
    UMCL, Slovenia    		 Thrombotic microangiopathy after onasemnogene abeparvovec

    13.40 - 14.20: Lunch break
    14.20 - 16.15: Neuromuscular / Rare 2

    Chairpersons: Tanja Loboda, Ivan Lehman

    Time Authors Title
    14.20 - 15.05 Roche Symposium
    Andres Nascimento Osorio
    Sant Joan de Déu, Spain

    		 Clinical Experiences with Evrysdi in Spain. A Review of SMA Treatment Outcomes
    15.05 - 15.25 Ivan Lehman
    KBC Zagreb, Croatia    		 Croatia’s Journey in SMA Care: Advancements in Gene Therapy and Newborn Screening
    15.25 - 15.45 Rok Kučan, Tanja Loboda, Tanja Golli, Tomaž Prelog
    UMCL, Slovenia    		 GBS after treatment of T-cell lymphoma
    15.45 - 16.15 Biogen Symposium
    Tita Butenko
    UMCL, Slovenia    		 Novel treatment option for Friedreich ataxia

    16.15 - 16.35: Coffee break
    16.35 - 17.55: Immune-mediated neurological diseas 1 

    Chairpersons:  Jasna Jančić & Neli Bizjak

    Time Authors Title
    16.35 - 16.55 Kevin Rostasy
    Department of Pediatric Neurology,
    Children’s Hospital Datteln,
    University Witten/Herdecke, Datteln, Germany    		 Spectrum of autoimmune mediated diseases of the CNS in children
    16.55 - 17.15 Tatjana Pekmezović
    University of Belgrade,
    Institute of Epidemiology, Serbia    		 Epidemiology of MS in children and adolescents
    17.15 - 17.35 Jasna Jančić
    Clinic of Neurology and Psychiatry
    for Children and Youth, Belgrade, Serbia    		 Challenges in treating MS in childhood and adolescence
    17.35 - 17.55 Jelena Drulović
    MS Centre, Clinic of Neurology,
    University Clinical Centre of Serbia in Belgrade, Serbia    		 Brain-health time matters: Early intervention is critical in multiple sclerosis


  • 9.00 - 11.00: Immune-mediated neurological diseas 2

    Chairpersons:  Jasna Jančić, Neli Bizjak

    Time Authors Title
    9.00 - 9.20 Blažo Nikolić 
    Clinic of Neurology and Psychiatry
    for Children and Youth, Belgrade, Serbia    		 Evoked potentials: Current and future biomarkers in childhood and adolescence multiple sclerosis
    9.20 - 9.40 Gregor Brecl Jakob
    Department of Neurology, UMCL, Slovenia    		 Clinical and Paraclinical correlates of neurodegeneration in MS
    9.40 - 10.00 Neli Bizjak
    Department of Pediatric Neurology, UMCL, Slovenia    		 Acute Visual Loss in Children: Optic Neuritis vs Optic Neuropathy
    10.00 - 10.20 Nelica Radovič Ivanović
    Institute for Children's diseases, Clinical center
    of Montenegro    		 Immune-mediated cerebellar ataxia: Diagnostic and therapeutic challenges
    10.20 - 10.40 Jadranka Sekelj Fureš
    Children’s Hospital Zagreb, Croatia    		 Therapeutic effect of MET and HET in Croatian POMS patients- where do we stand?

    11.00 - 11.20: Coffee break
    11.20 - 14.35: Neurointensive care

    Chairpersons: Petja Fister
    Time Authors Title
    11.20 - 11.50 Astra Zeneca Symposium
    Neli Bizjak
    UMCL, Slovenia    		 Pyridoxine-responsive seizures. Insights and the link to hypophosphatasia
    11.50 - 12.35 Joseph Scafidi, DO, M.S.
    Kennedy Krieger Institute, Johns Hopkins
    School of Medicine, USA    		 Critical Periods of pre- and post-natal brain development - Online
    12.35 - 12.55 Tanja Kranjc Božič
    UMCL, Slovenia    		 Traumatic brain injury
    12.55 - 13.15 Maša Bizjak, Tanja Dukič Vukovič
    UMCL, Slovenia    		 Dissection of vertebral artery – a case report
    13.15 - 13.35 Urška Mahne, Peter Spazzapan
    UMCL, Slovenia    		 Postoperative treatment of pediatric neurosurgical patients
    13.35 - 14.05 Barbara Plecko
    LKH-Univ.-Klinikum Graz, Austria    		 Advances in the treatment of neurometabolic disorders
    14.05 - 14.35 Pavel Kršek
    Second Faculty of Medicine, Charles University,
    Czech Republic    		 Genetic testing as a standard component of pre-surgical evaluation of pediatric drug-resistant epilepsy
    14.35 - 15.05 PTC Symposium
    Damjan Osredkar
    UCML, Slovenia    		 Aromatic Amino Acid Decarboxlase Deficiency (AADCd)

    15.05 - 15.30: Lunch
    15.30 - 18.30: Epilepsy

    Chairpersons:  Mirjana Perkovič Benedik, Ružica Kravljanac

    Time Authors Title
    15.30 - 16.00 BioMarin Symposium
    Igor Prpić
    Pediatrična klinika KBC Reka, Croatia    		 The different faces of CLN2
    16.00 - 16.20 Ružica Kravljanac
    Institute for Mother and Child Healthcare of Serbia    		 Is the current definition of status epilepticus applicable in children?
    16.20 - 16.40 Vladimir Oparnica, Ružica Kravljanac
    Institute for Mother and Child Healthcare of Serbia    		 Etiology and clinical features of status epilepticus in children – the experience of tertiary center
    16.40 - 17.00 Zvonka Rener Primec, Mirjana Perkovič Benedik
    UMCL, Slovenia    		 Vagus nerve stimulation for pharmacoresistant epilepsy
    17.00 - 17.20 Djordje Kravljanac
    Institute for Mother and Child Healthcare of Serbia    		 Severe „epiburns“ in children
    17.20 - 17.40 Sofija Popović, Ružica Kravljanac,
    Biljana Vučetić Tadić
    Institute for Mother and Child Healthcare of Serbia    		 Central apnea – ictal phenomenon or not?
    17.40 - 17.50 Filip Duma
    North Macedonia    		 Unoperable child with resistant epilepsy with a long hystory of seizures and unsuccsesful tretament
    17.50 - 18.20 Swixx BioPharma Symposium
    Mirjana Perković Benedik
    UMCL, Slovenia    		 Treatment of refractory epilepsies with novel antiseizure medications
    18.20 - 18.30 Damjan Osredkar
    UMCL, Slovenia    		 Closing remarks
  • Session 1:
    NEURODEVELOPMENT AND FETAL NEUROLOGY
     
    Development of connectivity in the human fetal brain: synapse-rich compartment and axonal pathways
    Ivica Kostović, Croatian Institute for Brain Research · School of Medicine, University of Zagreb, Croatia
    Approach to cortical malformations - pre- and postnatal imaging, clinical presentation and genetic diagnosis
    Tally Sagie, Edith Wolfson medical Center, Tel-Aviv, Israel
    Development of prenatal MR imaging at the University Medical Centre Ljubljana
    Tina Vipotnik, Dpt. of Radiology, UMCL, Slovenia
    Uncovering Early Predictors of Cerebral Palsy through the Application of Machine Learning
    Sara Rapuc, Blaž Stres, Damjan Osredkar, Miha Lučovnik, Dpt. of Pediatric neurology, UMCL, Slovenia
    Differential diagnosis of neonatal hypotonia - don't miss Prader Willi syndrome
    Gordana Kovačević, University of Belgrade, Insitute for Mother and child care of Serbia
    Neurological Outcome in Children of Mothers With Antiphospolipid Syndrome
    Mojca Zajc, Dpt. of Pediatric immunology, UMCL, Slovenia
    Satellite Symposium Immedica Pharma: Arginase 1 Deficiency - Challenges of early diagnostics

    15 minutes COFFEE BREAK

    Session 2:
    OPEN SESSION 1


    Correlation between Phenotype and Genotype in CTNNB1 Syndrome
    Nina Žakelj, David Gosar, Jasna Oražem Mrak, Damjan Osredkar, Dpt. of Pediatric neurology, UMCL, Slovenia
    Epidemiological and clinical characteristics of migraine in childhood and adolescence - single center experience
    Tamara Ristić, Child and Youth Healthcare Institute of Vojvodina, Novi Sad, Serbia
    The genetic landscape of LGG in Slovenian pediatric cohort
    Nataša Šuštar, Barbara Faganel Kotnik, Zvonka Rener Primec, Jernej Mlakar, Jože Pižem, Lidija Kitanovski, Dpt. of Pediatric neurology, UMCL, Slovenia
    Overview of Friedreich's Ataxia
    Shpresa Pula, University College London Hospitals NHS, UK
    "Stroke stat" care
    Kaja Silič, Zvonka Rener Primec, UMCL, Slovenia
    Satellite Symposium

    Session 3:
    SLEEP DISORDERS 

    Title TBD
    Barbara Gnidovec Stražišar, General Hospital Celje, Slovenia
    Sleep quality and tic severity in school children with Tourette syndrome
    Tjaša Vranetič, Gorjan Tasevski, Staša Stropnik, Jasna Oražem Mrak, Dpt. of Pediatric neurology, UMCL, Slovenia

    15 minutes COFFEE BREAK

    Session 4:
    OPEN SESSION 2

    Clinical presentation of neurocutaneous syndromes - tertiary center experience
    Jovana Bedjik, Institute for Mother and Child Healthcare of Serbia
    Epilepsies in Neurocutaneus Syndromes
    Aleksandar Dimitrijević, University Children's Clinic Tiršova, Serbia
    Molecular targeted therapy for patients with NF type 1
    Tanja Golli, Milica Stefanović, Tanja Loboda, Dpt. of Pediatric Neurology, UMCL, Slovenia
    The challenges of surgery of neurofibromas in children with NF1
    Djordje Kravljanac, Faculty of Medicine, University of Belgrade, Institute for Mother and Child Healthcare of Serbia
    Best practices for the clinical management of chronic pain in children and adolescents
    Minna Ståhl, Hatanpää Hospital, Finland
    Satellite Symposium 
  • Session 5:
    FUNCTIONAL NEUROLOGICAL DISORDERS
     
    Functional neurological disorders
    Kasia Kozlowska, The Children's Hospital at Westmead Clinical School, University of Sydney, Australia
    Where the mind meets the body - Changing the paradigm of understanding and treatment of functional neurological disorders
    Borče Micev, Dpt. Of Child Psychiatry, UMCL, Slovenia
     
    Session 6:
    NEUROMUSCULAR DISORDERS 1

    The future of screening programs,
    Laurent Servais, MDUK Oxford Neuromuscular Centre, United Kingdom
    Satellite Symposium Novartis: Single centre experience with onasemnogene abeparvovec therapy in SMA
    Markéta Kumhera
    Change of paradigm and new therapeutic challenges in treatment of SMA patients
    Dimitrije Nikolić, Faculty of Medicine, University of Belgrade, University Children Clinic, Serbia
    Satellite Symposium Roche: Spinal muscular atrophy in the era of new treatments
    Laurent Servais, MDUK Oxford Neuromuscular Centre, United Kingdom
     
    Session 7:
    NEUROMUSCULAR DISORDERS 2
     
    Muscular dystrophy
    Gordana Kovačević, Faculty of Medicine, University of Belgrade, Instutute for Mother and Child Health Care of Serbia
    ActiLiege Next - how to use technology to follow NMD patients
    Eva Vrščaj, Tanja Golli, Damjan Osredkar, Dpt. of Pediatric neurology, UMCL, Slovenia
    Novel therapeutic approaches to treatment of rare diseases
    Damjan Osredkar, Dpt. of Pediatric neurology, UMCL, Slovenia
    Satellite Symposium

    15 minutes COFFEE BREAK

    Session 8:
    EPILEPSY
     
    Epilepsy surgery in children
    Thomas Cloppenborg, Bethel Epilepsy Center, Mara Hospital, Bielefeld, Germany
    Assessment of genetic aetiology in children with pharmacoresistant epilepsy in a tertiary centre over a two-year period
    Karmen Krejan, Ana Katarina Žgajnar, Neli Bizjak, Damjan Osredkar, Mirjana Perkovič Benedik in sod., Dpt. of Pediatric neurology, UMCL, Slovenia
    Pyridoxine responsive epilepsy - the outcome predictors
    Ružica Kravljanac, Faculty of Medicine, University of Belgrade, Institute for Mother and Child Healthcare of Serbia
    The role of corticosteroids and IVIG in treatment of childhood epileptic encephalopathies
    Nikola Ivančević, Clinic of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia
    Exome sequencing data, MRI and clinical heterogeneity in 514 patients with epilepsy
    Mihael Rogač, KIGM, UMCL, Slovenia
    Status Epilepticus in Sleep
    Nelica Ivanović Radović, Institute for child disease, Clinical centre of Montenegro
    Epilepsies in Children With Cerebral Palsy
    Ljiljana Globarević, Institute for child disease, Clinical centre of Montenegro
     
    15 minutes COFFEE BREAK

    Session 9:
    OPEN SESSION 3

    The microbiome and non-communicable diseases: wgs and chemistry
    Blaž Stres, Institute Jožef Stefan, Ljubljana, Slovenia
    Cerebral Palsy and Genetics
    Ana Trebše, Ula Arkar, Mihael Rogač, Jernej Kovač, Damjan Osredkar, Dpt. of Pediatric neurology, UMCL, Slovenia
    Genetic diagnostics of mitochondrial diseases
    Jernej Kovač, Institute for Special Laboratory Diagnostics, UMCL, Slovenia
    Diagnostic yield of genetic, metabolic and imaging studies in children with global developmental delay
    Airin Veronese, Damjan Osredkar, Luca Lovrečič, Anja Troha Gergeli, Dpt. of Pediatric neurology, UMCL, Slovenia
    Safety and tolerability of full spectrum cannabis oil (CBD:THC 10:1) for treatment of spasticity in children and young adults with cerebral palsy
    Milica Stefanović, Zvonka Rener Primec, Damjan Osredkar, David Neubauer, Department of Oncology, UMCL, Slovenia
    Child-parent professional approaches in preventing and managing pain in children with cerebral palsy
    Darko Milaščevič, Hôpital Armand Trousseau, Paris, France